1. Home
  2. SER vs UBXG Comparison

SER vs UBXG Comparison

Compare SER & UBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • UBXG
  • Stock Information
  • Founded
  • SER 2017
  • UBXG 2018
  • Country
  • SER United States
  • UBXG China
  • Employees
  • SER N/A
  • UBXG N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • UBXG
  • Sector
  • SER Health Care
  • UBXG
  • Exchange
  • SER Nasdaq
  • UBXG Nasdaq
  • Market Cap
  • SER 56.5M
  • UBXG 67.8M
  • IPO Year
  • SER 2018
  • UBXG 2024
  • Fundamental
  • Price
  • SER $5.40
  • UBXG $3.10
  • Analyst Decision
  • SER Strong Buy
  • UBXG
  • Analyst Count
  • SER 2
  • UBXG 0
  • Target Price
  • SER $13.00
  • UBXG N/A
  • AVG Volume (30 Days)
  • SER 25.7K
  • UBXG 21.3K
  • Earning Date
  • SER 08-11-2025
  • UBXG 01-01-0001
  • Dividend Yield
  • SER N/A
  • UBXG N/A
  • EPS Growth
  • SER N/A
  • UBXG N/A
  • EPS
  • SER N/A
  • UBXG N/A
  • Revenue
  • SER $130,000.00
  • UBXG $39,603,353.00
  • Revenue This Year
  • SER N/A
  • UBXG N/A
  • Revenue Next Year
  • SER N/A
  • UBXG N/A
  • P/E Ratio
  • SER N/A
  • UBXG N/A
  • Revenue Growth
  • SER N/A
  • UBXG N/A
  • 52 Week Low
  • SER $3.81
  • UBXG $2.36
  • 52 Week High
  • SER $10.28
  • UBXG $567.04
  • Technical
  • Relative Strength Index (RSI)
  • SER 48.70
  • UBXG N/A
  • Support Level
  • SER $5.02
  • UBXG N/A
  • Resistance Level
  • SER $5.63
  • UBXG N/A
  • Average True Range (ATR)
  • SER 0.40
  • UBXG 0.00
  • MACD
  • SER 0.02
  • UBXG 0.00
  • Stochastic Oscillator
  • SER 29.03
  • UBXG 0.00

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.

Share on Social Networks: